Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis.
OBJECTIVE: To evaluate the efficacy and safety of tumor necrosis factor (TNF) inhibition with the p55 TNF receptor fusion protein (TNFr-Ig) for severe sight-threatening noninfectious posterior segment intraocular inflammation. METHODS: Seventeen patients with refractory noninfectious posterior segm...
Main Authors: | Murphy, C, Greiner, K, Plskova, J, Duncan, L, Frost, A, Isaacs, J, Rebello, P, Waldmann, H, Hale, G, Forrester, J, Dick, A |
---|---|
Format: | Journal article |
Sprog: | English |
Udgivet: |
2004
|
Lignende værker
-
Intravitreal steroid implants in the management of noninfectious intermediate and posterior uveitis
af: Sarjak M Shah, et al.
Udgivet: (2025-01-01) -
Intraocular therapy in noninfectious uveitis
af: Rocco Luigi Modugno, et al.
Udgivet: (2021-10-01) -
Emerging Therapies for Noninfectious Uveitis: What May Be Coming to the Clinics
af: Jose R. Maya, et al.
Udgivet: (2014-01-01) -
Efficacy of Ozurdex implant in treatment of noninfectious intermediate uveitis
af: Swetha Palla, et al.
Udgivet: (2015-01-01) -
Campath-1H therapy in refractory ocular inflammatory disease.
af: Dick, A, et al.
Udgivet: (2000)